Related Experiment Video
Updated: Jul 15, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Myocardial Infarction in Polycythemia Vera and Dengue: A Case of Competing Risks
Maria Teresa Politi1, Guido Vannoni2, Juan Gagliardi2
1Physiology, Universidad de Buenos Aires, Buenos Aires, ARG.
This case highlights a rare instance of myocardial infarction in a patient with polycythemia vera and dengue infection. Management involved balancing thrombosis and bleeding risks, ultimately deferring invasive procedures.
Area of Science:
- Cardiology
- Infectious Diseases
- Hematology
Background:
- A 71-year-old male with polycythemia vera and prior myocardial infarction presented with symptoms suggestive of acute coronary syndrome.
- The patient also had an acute dengue infection, complicating his cardiovascular presentation.
Observation:
- Electrocardiography showed ischemic changes and elevated troponin T, while NS1 antigen testing confirmed dengue infection.
- Laboratory results revealed erythrocytosis, mild thrombocytopenia, and worsening renal function.
Findings:
- The patient was diagnosed with myocardial infarction secondary to polycythemia vera-induced hypercoagulability and dengue-associated thrombocytopenia.
- Due to high bleeding risk and spontaneous symptom resolution, percutaneous coronary intervention was deferred.
Implications:
- This case illustrates the complex management challenges in patients with coexisting hypercoagulable states and infections causing thrombocytopenia.
- A multidisciplinary approach is crucial for optimizing outcomes in high-risk cardiovascular patients with overlapping conditions.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...